COVID-19 Impact on Global Small Molecule Targeted Cancer Therapy Market Size, Status and Forecast 2020-2026

September 2020 | 99 pages | ID: CC1C637F674FEN
QYResearch

Abstracts

This report focuses on the global Small Molecule Targeted Cancer Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Small Molecule Targeted Cancer Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• OncoGenex Pharmaceuticals, Inc.
• Cytokinetics Inc.
• Hospira Inc.
• GlaxoSmithKline plc
• Boehringer Ingelheim GmbH
• Bayer HealthCare AG
• Abbott Laboratories

Market segment by Type, the product can be split into

• Monoclonal Antibodies
• Small Molecules
• Small Molecule Drug Conjugates

Market segment by Application, split into

• Lymphoma
• Melanoma
• Multiple Myeloma
• Breast Cancer
• Prostate Cancer
• Other Cancers

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Small Molecule Targeted Cancer Therapy status, future forecast, growth opportunity, key market and key players.
• To present the Small Molecule Targeted Cancer Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Small Molecule Targeted Cancer Therapy are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Small Molecule Targeted Cancer Therapy Revenue
1.4 Market Analysis by Type
  1.4.1 Global Small Molecule Targeted Cancer Therapy Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Monoclonal Antibodies
  1.4.3 Small Molecules
  1.4.4 Small Molecule Drug Conjugates
1.5 Market by Application
  1.5.1 Global Small Molecule Targeted Cancer Therapy Market Share by Application: 2020 VS 2026
  1.5.2 Lymphoma
  1.5.3 Melanoma
  1.5.4 Multiple Myeloma
  1.5.5 Breast Cancer
  1.5.6 Prostate Cancer
  1.5.7 Other Cancers
1.6 Coronavirus Disease 2019 (Covid-19): Small Molecule Targeted Cancer Therapy Industry Impact
  1.6.1 How the Covid-19 is Affecting the Small Molecule Targeted Cancer Therapy Industry
    1.6.1.1 Small Molecule Targeted Cancer Therapy Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Small Molecule Targeted Cancer Therapy Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Small Molecule Targeted Cancer Therapy Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Small Molecule Targeted Cancer Therapy Market Perspective (2015-2026)
2.2 Small Molecule Targeted Cancer Therapy Growth Trends by Regions
  2.2.1 Small Molecule Targeted Cancer Therapy Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Small Molecule Targeted Cancer Therapy Historic Market Share by Regions (2015-2020)
  2.2.3 Small Molecule Targeted Cancer Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Small Molecule Targeted Cancer Therapy Market Growth Strategy
  2.3.6 Primary Interviews with Key Small Molecule Targeted Cancer Therapy Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Small Molecule Targeted Cancer Therapy Players by Market Size
  3.1.1 Global Top Small Molecule Targeted Cancer Therapy Players by Revenue (2015-2020)
  3.1.2 Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Players (2015-2020)
  3.1.3 Global Small Molecule Targeted Cancer Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Small Molecule Targeted Cancer Therapy Market Concentration Ratio
  3.2.1 Global Small Molecule Targeted Cancer Therapy Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Small Molecule Targeted Cancer Therapy Revenue in 2019
3.3 Small Molecule Targeted Cancer Therapy Key Players Head office and Area Served
3.4 Key Players Small Molecule Targeted Cancer Therapy Product Solution and Service
3.5 Date of Enter into Small Molecule Targeted Cancer Therapy Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Small Molecule Targeted Cancer Therapy Historic Market Size by Type (2015-2020)
4.2 Global Small Molecule Targeted Cancer Therapy Forecasted Market Size by Type (2021-2026)

5 SMALL MOLECULE TARGETED CANCER THERAPY BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Small Molecule Targeted Cancer Therapy Market Size by Application (2015-2020)
5.2 Global Small Molecule Targeted Cancer Therapy Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Small Molecule Targeted Cancer Therapy Market Size (2015-2020)
6.2 Small Molecule Targeted Cancer Therapy Key Players in North America (2019-2020)
6.3 North America Small Molecule Targeted Cancer Therapy Market Size by Type (2015-2020)
6.4 North America Small Molecule Targeted Cancer Therapy Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Small Molecule Targeted Cancer Therapy Market Size (2015-2020)
7.2 Small Molecule Targeted Cancer Therapy Key Players in Europe (2019-2020)
7.3 Europe Small Molecule Targeted Cancer Therapy Market Size by Type (2015-2020)
7.4 Europe Small Molecule Targeted Cancer Therapy Market Size by Application (2015-2020)

8 CHINA

8.1 China Small Molecule Targeted Cancer Therapy Market Size (2015-2020)
8.2 Small Molecule Targeted Cancer Therapy Key Players in China (2019-2020)
8.3 China Small Molecule Targeted Cancer Therapy Market Size by Type (2015-2020)
8.4 China Small Molecule Targeted Cancer Therapy Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Small Molecule Targeted Cancer Therapy Market Size (2015-2020)
9.2 Small Molecule Targeted Cancer Therapy Key Players in Japan (2019-2020)
9.3 Japan Small Molecule Targeted Cancer Therapy Market Size by Type (2015-2020)
9.4 Japan Small Molecule Targeted Cancer Therapy Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Small Molecule Targeted Cancer Therapy Market Size (2015-2020)
10.2 Small Molecule Targeted Cancer Therapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Small Molecule Targeted Cancer Therapy Market Size by Type (2015-2020)
10.4 Southeast Asia Small Molecule Targeted Cancer Therapy Market Size by Application (2015-2020)

11 INDIA

11.1 India Small Molecule Targeted Cancer Therapy Market Size (2015-2020)
11.2 Small Molecule Targeted Cancer Therapy Key Players in India (2019-2020)
11.3 India Small Molecule Targeted Cancer Therapy Market Size by Type (2015-2020)
11.4 India Small Molecule Targeted Cancer Therapy Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Small Molecule Targeted Cancer Therapy Market Size (2015-2020)
12.2 Small Molecule Targeted Cancer Therapy Key Players in Central & South America (2019-2020)
12.3 Central & South America Small Molecule Targeted Cancer Therapy Market Size by Type (2015-2020)
12.4 Central & South America Small Molecule Targeted Cancer Therapy Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 OncoGenex Pharmaceuticals, Inc.
  13.1.1 OncoGenex Pharmaceuticals, Inc. Company Details
  13.1.2 OncoGenex Pharmaceuticals, Inc. Business Overview and Its Total Revenue
  13.1.3 OncoGenex Pharmaceuticals, Inc. Small Molecule Targeted Cancer Therapy Introduction
  13.1.4 OncoGenex Pharmaceuticals, Inc. Revenue in Small Molecule Targeted Cancer Therapy Business (2015-2020))
  13.1.5 OncoGenex Pharmaceuticals, Inc. Recent Development
13.2 Cytokinetics Inc.
  13.2.1 Cytokinetics Inc. Company Details
  13.2.2 Cytokinetics Inc. Business Overview and Its Total Revenue
  13.2.3 Cytokinetics Inc. Small Molecule Targeted Cancer Therapy Introduction
  13.2.4 Cytokinetics Inc. Revenue in Small Molecule Targeted Cancer Therapy Business (2015-2020)
  13.2.5 Cytokinetics Inc. Recent Development
13.3 Hospira Inc.
  13.3.1 Hospira Inc. Company Details
  13.3.2 Hospira Inc. Business Overview and Its Total Revenue
  13.3.3 Hospira Inc. Small Molecule Targeted Cancer Therapy Introduction
  13.3.4 Hospira Inc. Revenue in Small Molecule Targeted Cancer Therapy Business (2015-2020)
  13.3.5 Hospira Inc. Recent Development
13.4 GlaxoSmithKline plc
  13.4.1 GlaxoSmithKline plc Company Details
  13.4.2 GlaxoSmithKline plc Business Overview and Its Total Revenue
  13.4.3 GlaxoSmithKline plc Small Molecule Targeted Cancer Therapy Introduction
  13.4.4 GlaxoSmithKline plc Revenue in Small Molecule Targeted Cancer Therapy Business (2015-2020)
  13.4.5 GlaxoSmithKline plc Recent Development
13.5 Boehringer Ingelheim GmbH
  13.5.1 Boehringer Ingelheim GmbH Company Details
  13.5.2 Boehringer Ingelheim GmbH Business Overview and Its Total Revenue
  13.5.3 Boehringer Ingelheim GmbH Small Molecule Targeted Cancer Therapy Introduction
  13.5.4 Boehringer Ingelheim GmbH Revenue in Small Molecule Targeted Cancer Therapy Business (2015-2020)
  13.5.5 Boehringer Ingelheim GmbH Recent Development
13.6 Bayer HealthCare AG
  13.6.1 Bayer HealthCare AG Company Details
  13.6.2 Bayer HealthCare AG Business Overview and Its Total Revenue
  13.6.3 Bayer HealthCare AG Small Molecule Targeted Cancer Therapy Introduction
  13.6.4 Bayer HealthCare AG Revenue in Small Molecule Targeted Cancer Therapy Business (2015-2020)
  13.6.5 Bayer HealthCare AG Recent Development
13.7 Abbott Laboratories
  13.7.1 Abbott Laboratories Company Details
  13.7.2 Abbott Laboratories Business Overview and Its Total Revenue
  13.7.3 Abbott Laboratories Small Molecule Targeted Cancer Therapy Introduction
  13.7.4 Abbott Laboratories Revenue in Small Molecule Targeted Cancer Therapy Business (2015-2020)
  13.7.5 Abbott Laboratories Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Small Molecule Targeted Cancer Therapy Key Market Segments
Table 2. Key Players Covered: Ranking by Small Molecule Targeted Cancer Therapy Revenue
Table 3. Ranking of Global Top Small Molecule Targeted Cancer Therapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Small Molecule Targeted Cancer Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Monoclonal Antibodies
Table 6. Key Players of Small Molecules
Table 7. Key Players of Small Molecule Drug Conjugates
Table 8. COVID-19 Impact Global Market: (Four Small Molecule Targeted Cancer Therapy Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Small Molecule Targeted Cancer Therapy Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Small Molecule Targeted Cancer Therapy Players to Combat Covid-19 Impact
Table 13. Global Small Molecule Targeted Cancer Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Small Molecule Targeted Cancer Therapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Small Molecule Targeted Cancer Therapy Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Small Molecule Targeted Cancer Therapy Market Share by Regions (2015-2020)
Table 17. Global Small Molecule Targeted Cancer Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Small Molecule Targeted Cancer Therapy Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Small Molecule Targeted Cancer Therapy Market Growth Strategy
Table 23. Main Points Interviewed from Key Small Molecule Targeted Cancer Therapy Players
Table 24. Global Small Molecule Targeted Cancer Therapy Revenue by Players (2015-2020) (Million US$)
Table 25. Global Small Molecule Targeted Cancer Therapy Market Share by Players (2015-2020)
Table 26. Global Top Small Molecule Targeted Cancer Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Small Molecule Targeted Cancer Therapy as of 2019)
Table 27. Global Small Molecule Targeted Cancer Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Small Molecule Targeted Cancer Therapy Product Solution and Service
Table 30. Date of Enter into Small Molecule Targeted Cancer Therapy Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Small Molecule Targeted Cancer Therapy Market Size by Type (2015-2020) (Million US$)
Table 33. Global Small Molecule Targeted Cancer Therapy Market Size Share by Type (2015-2020)
Table 34. Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Type (2021-2026)
Table 35. Global Small Molecule Targeted Cancer Therapy Market Size Share by Application (2015-2020)
Table 36. Global Small Molecule Targeted Cancer Therapy Market Size by Application (2015-2020) (Million US$)
Table 37. Global Small Molecule Targeted Cancer Therapy Market Size Share by Application (2021-2026)
Table 38. North America Key Players Small Molecule Targeted Cancer Therapy Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Small Molecule Targeted Cancer Therapy Market Share (2019-2020)
Table 40. North America Small Molecule Targeted Cancer Therapy Market Size by Type (2015-2020) (Million US$)
Table 41. North America Small Molecule Targeted Cancer Therapy Market Share by Type (2015-2020)
Table 42. North America Small Molecule Targeted Cancer Therapy Market Size by Application (2015-2020) (Million US$)
Table 43. North America Small Molecule Targeted Cancer Therapy Market Share by Application (2015-2020)
Table 44. Europe Key Players Small Molecule Targeted Cancer Therapy Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Small Molecule Targeted Cancer Therapy Market Share (2019-2020)
Table 46. Europe Small Molecule Targeted Cancer Therapy Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Small Molecule Targeted Cancer Therapy Market Share by Type (2015-2020)
Table 48. Europe Small Molecule Targeted Cancer Therapy Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Small Molecule Targeted Cancer Therapy Market Share by Application (2015-2020)
Table 50. China Key Players Small Molecule Targeted Cancer Therapy Revenue (2019-2020) (Million US$)
Table 51. China Key Players Small Molecule Targeted Cancer Therapy Market Share (2019-2020)
Table 52. China Small Molecule Targeted Cancer Therapy Market Size by Type (2015-2020) (Million US$)
Table 53. China Small Molecule Targeted Cancer Therapy Market Share by Type (2015-2020)
Table 54. China Small Molecule Targeted Cancer Therapy Market Size by Application (2015-2020) (Million US$)
Table 55. China Small Molecule Targeted Cancer Therapy Market Share by Application (2015-2020)
Table 56. Japan Key Players Small Molecule Targeted Cancer Therapy Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Small Molecule Targeted Cancer Therapy Market Share (2019-2020)
Table 58. Japan Small Molecule Targeted Cancer Therapy Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Small Molecule Targeted Cancer Therapy Market Share by Type (2015-2020)
Table 60. Japan Small Molecule Targeted Cancer Therapy Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Small Molecule Targeted Cancer Therapy Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Small Molecule Targeted Cancer Therapy Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Small Molecule Targeted Cancer Therapy Market Share (2019-2020)
Table 64. Southeast Asia Small Molecule Targeted Cancer Therapy Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Small Molecule Targeted Cancer Therapy Market Share by Type (2015-2020)
Table 66. Southeast Asia Small Molecule Targeted Cancer Therapy Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Small Molecule Targeted Cancer Therapy Market Share by Application (2015-2020)
Table 68. India Key Players Small Molecule Targeted Cancer Therapy Revenue (2019-2020) (Million US$)
Table 69. India Key Players Small Molecule Targeted Cancer Therapy Market Share (2019-2020)
Table 70. India Small Molecule Targeted Cancer Therapy Market Size by Type (2015-2020) (Million US$)
Table 71. India Small Molecule Targeted Cancer Therapy Market Share by Type (2015-2020)
Table 72. India Small Molecule Targeted Cancer Therapy Market Size by Application (2015-2020) (Million US$)
Table 73. India Small Molecule Targeted Cancer Therapy Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Small Molecule Targeted Cancer Therapy Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Small Molecule Targeted Cancer Therapy Market Share (2019-2020)
Table 76. Central & South America Small Molecule Targeted Cancer Therapy Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Small Molecule Targeted Cancer Therapy Market Share by Type (2015-2020)
Table 78. Central & South America Small Molecule Targeted Cancer Therapy Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Small Molecule Targeted Cancer Therapy Market Share by Application (2015-2020)
Table 80. OncoGenex Pharmaceuticals, Inc. Company Details
Table 81. OncoGenex Pharmaceuticals, Inc. Business Overview
Table 82. OncoGenex Pharmaceuticals, Inc. Product
Table 83. OncoGenex Pharmaceuticals, Inc. Revenue in Small Molecule Targeted Cancer Therapy Business (2015-2020) (Million US$)
Table 84. OncoGenex Pharmaceuticals, Inc. Recent Development
Table 85. Cytokinetics Inc. Company Details
Table 86. Cytokinetics Inc. Business Overview
Table 87. Cytokinetics Inc. Product
Table 88. Cytokinetics Inc. Revenue in Small Molecule Targeted Cancer Therapy Business (2015-2020) (Million US$)
Table 89. Cytokinetics Inc. Recent Development
Table 90. Hospira Inc. Company Details
Table 91. Hospira Inc. Business Overview
Table 92. Hospira Inc. Product
Table 93. Hospira Inc. Revenue in Small Molecule Targeted Cancer Therapy Business (2015-2020) (Million US$)
Table 94. Hospira Inc. Recent Development
Table 95. GlaxoSmithKline plc Company Details
Table 96. GlaxoSmithKline plc Business Overview
Table 97. GlaxoSmithKline plc Product
Table 98. GlaxoSmithKline plc Revenue in Small Molecule Targeted Cancer Therapy Business (2015-2020) (Million US$)
Table 99. GlaxoSmithKline plc Recent Development
Table 100. Boehringer Ingelheim GmbH Company Details
Table 101. Boehringer Ingelheim GmbH Business Overview
Table 102. Boehringer Ingelheim GmbH Product
Table 103. Boehringer Ingelheim GmbH Revenue in Small Molecule Targeted Cancer Therapy Business (2015-2020) (Million US$)
Table 104. Boehringer Ingelheim GmbH Recent Development
Table 105. Bayer HealthCare AG Company Details
Table 106. Bayer HealthCare AG Business Overview
Table 107. Bayer HealthCare AG Product
Table 108. Bayer HealthCare AG Revenue in Small Molecule Targeted Cancer Therapy Business (2015-2020) (Million US$)
Table 109. Bayer HealthCare AG Recent Development
Table 110. Abbott Laboratories Company Details
Table 111. Abbott Laboratories Business Overview
Table 112. Abbott Laboratories Product
Table 113. Abbott Laboratories Revenue in Small Molecule Targeted Cancer Therapy Business (2015-2020) (Million US$)
Table 114. Abbott Laboratories Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Small Molecule Targeted Cancer Therapy Market Share by Type: 2020 VS 2026
Figure 2. Monoclonal Antibodies Features
Figure 3. Small Molecules Features
Figure 4. Small Molecule Drug Conjugates Features
Figure 5. Global Small Molecule Targeted Cancer Therapy Market Share by Application: 2020 VS 2026
Figure 6. Lymphoma Case Studies
Figure 7. Melanoma Case Studies
Figure 8. Multiple Myeloma Case Studies
Figure 9. Breast Cancer Case Studies
Figure 10. Prostate Cancer Case Studies
Figure 11. Other Cancers Case Studies
Figure 12. Small Molecule Targeted Cancer Therapy Report Years Considered
Figure 13. Global Small Molecule Targeted Cancer Therapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Small Molecule Targeted Cancer Therapy Market Share by Regions: 2020 VS 2026
Figure 15. Global Small Molecule Targeted Cancer Therapy Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Small Molecule Targeted Cancer Therapy Market Share by Players in 2019
Figure 18. Global Top Small Molecule Targeted Cancer Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Small Molecule Targeted Cancer Therapy as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Small Molecule Targeted Cancer Therapy Revenue in 2019
Figure 20. North America Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. OncoGenex Pharmaceuticals, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. OncoGenex Pharmaceuticals, Inc. Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2015-2020)
Figure 29. Cytokinetics Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Cytokinetics Inc. Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2015-2020)
Figure 31. Hospira Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Hospira Inc. Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2015-2020)
Figure 33. GlaxoSmithKline plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. GlaxoSmithKline plc Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2015-2020)
Figure 35. Boehringer Ingelheim GmbH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Boehringer Ingelheim GmbH Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2015-2020)
Figure 37. Bayer HealthCare AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Bayer HealthCare AG Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2015-2020)
Figure 39. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Abbott Laboratories Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2015-2020)
Figure 41. Bottom-up and Top-down Approaches for This Report
Figure 42. Data Triangulation
Figure 43. Key Executives Interviewed